APTAMIR
USPTO Trademark Record · Serial No. 86457201
Trademark details
It was initially claimed by AptamiR Therapeutics, Inc. on 20141118.
That brand applies to the following goods and services:Biological preparations for research, laboratory use, and medical research laboratory diagnostic use, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto, Medicinal and biological preparations for pharmaceutical, clinical or medical treatment and medical diagnostic use, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto for the treatment of cardiovascular diseases, metabolic diseases, overweight, obesity, diabetes mellitus, dyslipidemia, liver steatosis (fatty liver disease), steatohepatitis, non-alcoholic fatty liver disease, atheroscler, MicroRNA-targeted pharmaceutical drug research and development in the field of biotech therapeutics; development of RNA-based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, namely, cardiovascular diseases, endocrine and metabolic diseases, obesity and weight disorders, hepatic and gastro-intestinal diseases, inflammatory diseases, and malignant diseases; Scien.
Currently that trademark is represented by trademark attorney(s): Alicia Morris Groos.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the APTAMIR trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
